Table 5 Tables in the YCDL database and number of variables
From: Continuous multimodal data supply chain and expandable clinical decision support for oncology
 | Table Category | Table Name | Table Description | Common | Breast | Colorectal | Lung | Gastric | Liver | Melanoma | Kidney | Prostate | Thyroid | Prostate | Bile duct | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | PT | Patient | PT_BASIC | Patient Basic Information | 20 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 20 |
2 | PT | Patient | PT_PHIS | Past History | 39 | 9 | 12 | Â | Â | Â | Â | Â | 1 | 2 | Â | Â | 63 |
3 | PT | Patient | PT_SHIS | Smoking History | 29 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 29 |
4 | PT | Patient | PT_DRNK | Drinking History | 33 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 33 |
5 | PT | Patient | PT_FMHS | Family History | 41 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 41 |
6 | PT | Patient | PT_BDMS | Body Measurement | 27 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 27 |
7 | DG | Diagnosis | DG_INFO | Visit Information | 27 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 27 |
8 | DG | Diagnosis | DG_ECHI | Copayment Policy | 27 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 27 |
9 | DG | Diagnosis | DG_CNCR | Cancer Diagnosis | 37 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 37 |
10 | DG | Diagnosis | DG_CONS | Consultant | 28 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 28 |
11 | EM | Examination | EM_LAB | Laboratory Test | 30 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 30 |
12 | EM | Examination | EM_IMEX | Imaging Test | 28 | Â | Â | 2 | Â | 2 | Â | Â | Â | Â | 2 | 2 | 36 |
13 | EM | Examination | EM_GENE | Genetic Test | 28 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 28 |
14 | EM | Examination | EM_FCLT | Function Test | 28 | 6 | Â | 5 | Â | 2 | Â | Â | Â | 6 | 2 | 2 | 51 |
15 | PH | Pathology | PH_BPSY | Biopsy | 29 | 7 | 13 | 4 | 13 | 5 | 5 | 3 | 7 | 3 | 4 | 4 | 97 |
16 | PH | Pathology | PH_SRGC | Histopathology | 32 | 29 | 36 | 20 | 19 | 34 | 23 | 24 | 16 | 25 | 20 | 33 | 311 |
17 | PH | Pathology | PH_IMML | Immuno-histology | 29 | 13 | 17 | 9 | 10 | 10 | 17 | 15 | 8 | 15 | 12 | 12 | 167 |
18 | OP | Operation | OP_INFO | Operation Information | 28 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 28 |
19 | OP | Operation | OP_OPNN | Operation opinion | 38 | 27 | 31 | 13 | 19 | 46 | 6 | 5 | 6 | 12 | 4 | 14 | 221 |
20 | OP | Operation | OP_COMP | Operation Complication | 25 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 25 |
21 | TX | Treatment | TX_CHTH | Chemotherapy | 36 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 36 |
22 | TX | Treatment | TX_RTH | Radiotherapy | 41 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 41 |
23 | TX | Treatment | TX_PRSC | Drug | 29 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 29 |
24 | TX | Treatment | TX_MOPR | Procedure | 33 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 33 |
25 | TE | Follow-Up | TE_MTST | Follow-Up Metastasis | 27 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 27 |
26 | TE | Follow-Up | TE_RCRN | Follow-Up Relapse | 23 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 23 |
27 | TE | Follow-Up | TE_DEAD | Dead | 25 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 25 |